Literature DB >> 7829676

Liver lesions found at colectomy in ulcerative colitis: correlation between histological findings and biochemical parameters.

J Mattila1, P Aitola, M Matikainen.   

Abstract

AIMS: To classify lesions discovered at colectomy in patients with ulcerative colitis; to assess the importance of histological findings by correlating them with biochemical parameters.
METHODS: Liver tissue specimens taken at colectomy from 59 patients with chronic ulcerative colitis were studied using light microscopy. The findings were compared with results of biochemical liver function tests.
RESULTS: Abnormal laboratory findings were found in 12 patients with liver histology consistent with primary sclerosing cholangitis. Non-specific reactive hepatitis was observed in six patients, eight had fatty liver, and three minor non-specific parenchymal changes. Twenty nine patients had normal liver histology. The highest cholestatic serum enzyme activities were seen in two patients with sclerosing cholangitis. Cholangiography in these patients also revealed changes in the extrahepatic bile ducts. However, identical histological changes were also present in patients with only slightly abnormal or even normal liver enzyme activities.
CONCLUSION: Biochemical tests of liver function do not reliably indicate the extent or severity of bile duct damage in ulcerative colitis, the assessment of which requires liver biopsy.

Entities:  

Mesh:

Year:  1994        PMID: 7829676      PMCID: PMC503065          DOI: 10.1136/jcp.47.11.1019

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

Review 1.  Surgical pathology of the syndrome of primary sclerosing cholangitis.

Authors:  J Ludwig
Journal:  Am J Surg Pathol       Date:  1989       Impact factor: 6.394

2.  Septicemia after endoscopic retrograde cholangiopancreatography.

Authors:  J Devière; S Motte; J M Dumonceau; E Serruys; J P Thys; M Cremer
Journal:  Endoscopy       Date:  1990-03       Impact factor: 10.093

3.  Primary sclerosing cholangitis with normal serum alkaline phosphatase activity.

Authors:  K Balasubramaniam; R H Wiesner; N F LaRusso
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

4.  The liver in ulcerative colitis.

Authors:  A D Perrett; G Higgins; H H Johnston; G R Massarella; S C Truelove; R Wright
Journal:  Q J Med       Date:  1971-04

5.  Liver disease in ulcerative colitis. I. Analysis of operative liver biopsy in 138 consecutive patients having colectomy.

Authors:  M N Eade
Journal:  Ann Intern Med       Date:  1970-04       Impact factor: 25.391

6.  Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study.

Authors:  G Sauter; B Grabein; G Huber; G A Mannes; G Ruckdeschel; T Sauerbruch
Journal:  Endoscopy       Date:  1990-07       Impact factor: 10.093

7.  The spectrum of hepatic dysfunction in inflammatory bowel disease.

Authors:  M J Dew; H Thompson; R N Allan
Journal:  Q J Med       Date:  1979-01

8.  Ultrastructural aspects of liver injury with special reference to small bile ducts in patients with ulcerative colitis.

Authors:  J Mattila; R Pitkänen; P Halonen; M Matikainen
Journal:  Liver       Date:  1992-08

9.  Current concepts. Primary sclerosing cholangitis.

Authors:  N F LaRusso; R H Wiesner; J Ludwig; R L MacCarty
Journal:  N Engl J Med       Date:  1984-04-05       Impact factor: 91.245

10.  Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?

Authors:  A Wee; J Ludwig
Journal:  Ann Intern Med       Date:  1985-05       Impact factor: 25.391

View more
  2 in total

1.  Changing shape of disease: nonalcoholic fatty liver disease in Crohn's disease-a case series and review of the literature.

Authors:  Christopher E McGowan; Patricia Jones; Millie D Long; A Sidney Barritt
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

2.  Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.

Authors:  Laszlo Lakatos; Tunde Pandur; Gyula David; Zsuzsanna Balogh; Pal Kuronya; Arpad Tollas; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.